Odyssey Therapeutics, Inc. ODTX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q1 '25 | ||
|---|---|---|---|---|
| $35.72M-35.0% | $41.69M— | $54.91M— | ||
| $140.03M— | $139.67M— | —— | ||
| $185.1M— | $190.66M— | —— | ||
| $6.56M— | $7.21M— | —— | ||
| $14.07M— | $14.33M— | —— | ||
| $160K— | $262K— | —— | ||
| $229.07M— | $269.79M— | —— | ||
| $8.22M— | $7.87M— | —— | ||
| $22.21M— | $26.48M— | —— | ||
| $49.21M— | $54.51M— | —— | ||
| $0— | $0— | —— | ||
| -$606.4M— | -$568.14M— | —— | ||
| -$523.69M-25.5% | -$488.28M-27.6% | -$417.17M— | ||
| $229.07M— | $269.79M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Odyssey Therapeutics, Inc.'s total assets?
- Odyssey Therapeutics, Inc. (ODTX) holds $229.1M in total assets.
- How much debt does Odyssey Therapeutics, Inc. have?
- Odyssey Therapeutics, Inc. carries $26.1M in total debt against -$523.7M of shareholders' equity, a debt-to-equity ratio of -0.05.
- How much cash does Odyssey Therapeutics, Inc. have?
- Odyssey Therapeutics, Inc. holds $35.7M in cash and equivalents.
- Can Odyssey Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 8.33 — current assets exceed current liabilities.
- Where does Odyssey Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Odyssey Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.